Plasma glucose regulation and mortality in Korea: A pooled analysis of three community-based cohort studies
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, N.H. | - |
dc.contributor.author | Kim, D.-J. | - |
dc.contributor.author | Park, S.W. | - |
dc.contributor.author | Oh, J.-Y. | - |
dc.contributor.author | Park, J.-Y. | - |
dc.contributor.author | Shin, C. | - |
dc.contributor.author | Lee, H.K. | - |
dc.contributor.author | Park, Y. | - |
dc.date.accessioned | 2021-09-05T16:12:11Z | - |
dc.date.available | 2021-09-05T16:12:11Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2014 | - |
dc.identifier.issn | 2233-6079 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/100830 | - |
dc.description.abstract | Background: Although diabetes is a well-known risk factor for death, its impact on cancer death is not clearly understood. Furthermore, it remains controversial whether impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are associated with increased risk of mortality. We investigated the impact of diabetes or glucose tolerance categories on all cause and cause-specific mortality. Methods: Mortality analysis was conducted in three population-based cohort studies of 3,801 participants, divided according to fasting plasma glucose (FPG) (normal; stage 1 IFG [5.6<FPG≤6.1 mmol/L]; stage 2 IFG [6.1<FPG≤7.0 mmol/L]; diabetes mellitus [DM]-FPG); or 2-hour glucose after 75 g glucose loading (2hPG) (normal; IGT; DM-2hPG), or a combination of FPG and 2hPG criteria. Results: During a median follow-up of 11.0 years, 474 subjects died from all causes. Hazard ratios (HRs) for all cause death were higher in those with diabetes as defined by either FPG or 2hPG criteria than their normal counterparts (HR, 2.2, 95% confidence interval [CI], 1.6 to 2.9 for DM-FPG; HR, 2.0, 95% CI, 1.5 to 2.7 for DM-2hPG). Similarly, diabetes defined by either FPG or 2hPG was associated with cancer death (HR, 2.9, 95% CI, 1.7 to 5.0; and HR, 2.1, 95% CI, 1.2 to 3.9, respectively). Although neither IFG nor IGT conferred higher risk for death, when combining stage 2 IFG and/or IGT, the risk of all cause death was higher than in subjects with normal glucose regulation (HR, 1.3; 95% CI, 1.0 to 1.6). Conclusion: Diabetes is associated with higher risk of death from all causes and cancer. In subjects without diabetes, stage 2 IFG and/or IGT confers increased risk for mortality. © 2014 Korean Diabetes Association. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Diabetes Association | - |
dc.subject | glucose | - |
dc.subject | high density lipoprotein cholesterol | - |
dc.subject | triacylglycerol | - |
dc.subject | adult | - |
dc.subject | article | - |
dc.subject | cause of death | - |
dc.subject | cholesterol blood level | - |
dc.subject | cohort analysis | - |
dc.subject | controlled study | - |
dc.subject | diabetes mellitus | - |
dc.subject | disease association | - |
dc.subject | female | - |
dc.subject | glucose blood level | - |
dc.subject | glucose tolerance | - |
dc.subject | glucose tolerance test | - |
dc.subject | hazard ratio | - |
dc.subject | human | - |
dc.subject | impaired glucose tolerance | - |
dc.subject | Korea | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | mortality | - |
dc.subject | prevalence | - |
dc.subject | triacylglycerol blood level | - |
dc.title | Plasma glucose regulation and mortality in Korea: A pooled analysis of three community-based cohort studies | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, C. | - |
dc.identifier.doi | 10.4093/dmj.2014.38.1.44 | - |
dc.identifier.scopusid | 2-s2.0-84897904709 | - |
dc.identifier.bibliographicCitation | Diabetes and Metabolism Journal, v.38, no.1, pp.44 - 50 | - |
dc.relation.isPartOf | Diabetes and Metabolism Journal | - |
dc.citation.title | Diabetes and Metabolism Journal | - |
dc.citation.volume | 38 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 44 | - |
dc.citation.endPage | 50 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001849220 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | glucose | - |
dc.subject.keywordPlus | high density lipoprotein cholesterol | - |
dc.subject.keywordPlus | triacylglycerol | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | cause of death | - |
dc.subject.keywordPlus | cholesterol blood level | - |
dc.subject.keywordPlus | cohort analysis | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | disease association | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | glucose blood level | - |
dc.subject.keywordPlus | glucose tolerance | - |
dc.subject.keywordPlus | glucose tolerance test | - |
dc.subject.keywordPlus | hazard ratio | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | impaired glucose tolerance | - |
dc.subject.keywordPlus | Korea | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | mortality | - |
dc.subject.keywordPlus | prevalence | - |
dc.subject.keywordPlus | triacylglycerol blood level | - |
dc.subject.keywordAuthor | Diabetes mellitus | - |
dc.subject.keywordAuthor | Glucose intolerance | - |
dc.subject.keywordAuthor | Mortality | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.